Related Experiment Video
Updated: Mar 11, 2026

04:42
Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
Published on: June 26, 2018
15.3K
Lack of electrical interference between spinal cord stimulators and other implanted electrical pulse devices
Alaa Abd-Elsayed1, Ravi Grandhi2, Harsh Sachdeva3
1Department Anesthesiology, University of Cincinnati, Cincinnati, OH, USA; Department Anesthesiology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Journal of Clinical Anesthesia
|November 23, 2016
Summary
Spinal cord stimulators (SCSs) can be safely used with other implanted electrical devices, improving pain scores. This study shows no device interactions in patients with pacemakers, defibrillators, or bladder stimulators.
Area of Science:
- Neuromodulation
- Pain Management
- Medical Device Technology
Background:
- Spinal cord stimulators (SCSs) are established treatments for chronic pain.
- SCSs are typically indicated for failed back surgery syndrome, complex regional pain syndrome, or non-surgical candidates.
- The presence of another electrical pulse device is a relative contraindication for SCS implantation.
Observation:
- This study presents three cases of patients receiving SCS despite having other implanted electrical devices.
- Case 1: Failed back surgery syndrome patient with an implantable cardiac defibrillator (ICD) and SCS.
- Case 2: Non-surgical candidate with a pacemaker receiving SCS for occupational back pain.
- Case 3: Complex regional pain syndrome patient with a bladder stimulator and prior SCS receiving a revision.
Findings:
- No adverse interactions were observed between the co-implanted electrical devices.
- All three patients experienced significant improvements in pain scores following SCS trial.
Implications:
- Co-implantation of SCS with other electrical pulse devices may be a viable option for select patients.
- This approach can expand treatment possibilities for chronic pain management.
- Further research is warranted to establish guidelines for co-implantation of neuromodulation devices.

